Tsakiridis, T., Gouveia, A., Mesci, A., Vavassis, P., Berlin, A., Morgan, S. C., Perlis, N., Niazi, T., Thoms, J., Hotte, S. J., Wright, J. (2025). OCOG-RATIONAL: A phase II randomized trial of optimal recurrence-directed therapy (RDT) without or with androgen-deprivation therapy (ADT) in radio-recurrent oligo-metastatic castrate sensitive prostate cancer (romCSPC).. Journal of Clinical Oncology. https://doi.org/10.1200/jco.2025.43.5_suppl.tps305